Arvinas, Pfizer to grant commercial rights of experimental breast cancer drug to third party - Reuters

Reuters | Sept. 17, 2025, 5:49 p.m. | Original
Arvinas, Pfizer to grant commercial rights of experimental breast cancer drug to third party Reuters
Trump's DEI crackdown further strains US supply of aircraft mechanics, industry officials say - Reuters Five Point-backed WaterBridge jumps 14% in NYSE debut - Reuters